327 related articles for article (PubMed ID: 22784115)
1. Potassium channel KIR4.1 as an immune target in multiple sclerosis.
Srivastava R; Aslam M; Kalluri SR; Schirmer L; Buck D; Tackenberg B; Rothhammer V; Chan A; Gold R; Berthele A; Bennett JL; Korn T; Hemmer B
N Engl J Med; 2012 Jul; 367(2):115-23. PubMed ID: 22784115
[TBL] [Abstract][Full Text] [Related]
2. Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
Kraus V; Srivastava R; Kalluri SR; Seidel U; Schuelke M; Schimmel M; Rostasy K; Leiz S; Hosie S; Grummel V; Hemmer B
Neurology; 2014 Feb; 82(6):470-3. PubMed ID: 24415573
[TBL] [Abstract][Full Text] [Related]
3. Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity.
Imamura M; Higuchi O; Maeda Y; Mukaino A; Ueda M; Matsuo H; Nakane S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348803
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
Brickshawana A; Hinson SR; Romero MF; Lucchinetti CF; Guo Y; Buttmann M; McKeon A; Pittock SJ; Chang MH; Chen AP; Kryzer TJ; Fryer JP; Jenkins SM; Cabre P; Lennon VA
Lancet Neurol; 2014 Aug; 13(8):795-806. PubMed ID: 25008548
[TBL] [Abstract][Full Text] [Related]
5. Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Schirmer L; Srivastava R; Kalluri SR; Böttinger S; Herwerth M; Carassiti D; Srivastava B; Gempt J; Schlegel J; Kuhlmann T; Korn T; Reynolds R; Hemmer B
Ann Neurol; 2014 Jun; 75(6):810-28. PubMed ID: 24777949
[TBL] [Abstract][Full Text] [Related]
6. Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Nerrant E; Salsac C; Charif M; Ayrignac X; Carra-Dalliere C; Castelnovo G; Goulabchand R; Tisseyre J; Raoul C; Eliaou JF; Labauge P; Vincent T
Mult Scler; 2014 Nov; 20(13):1699-703. PubMed ID: 24756568
[TBL] [Abstract][Full Text] [Related]
7. Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
Nakajima M; Kawamura T; Tokui R; Furuta K; Sugino M; Nakanishi M; Okuyama S; Furukawa Y
Brain Res; 2013 Nov; 1537():340-9. PubMed ID: 24070676
[TBL] [Abstract][Full Text] [Related]
8. Low reliability of anti-KIR4.1
Marino M; Frisullo G; Di Sante G; Samengo DM; Provenzano C; Mirabella M; Pani G; Ria F; Bartoccioni E
Mult Scler; 2018 Jun; 24(7):910-918. PubMed ID: 28548026
[TBL] [Abstract][Full Text] [Related]
9. Disease mechanisms in MS: the potassium channel KIR4.1--a potential autoantigen in MS.
Racke MK
Nat Rev Neurol; 2012 Nov; 8(11):595-6. PubMed ID: 22986435
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
Chastre A; Hafler DA; O'Connor KC
N Engl J Med; 2016 Apr; 374(15):1495-6. PubMed ID: 27074083
[No Abstract] [Full Text] [Related]
11. Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.
Malyavantham K; Weinstock-Guttman B; Suresh L; Zivadinov R; Shanahan T; Badgett D; Ramanathan M
PLoS One; 2015; 10(6):e0129503. PubMed ID: 26065913
[TBL] [Abstract][Full Text] [Related]
12. Increased anti-KIR4.1 antibodies in multiple sclerosis: could it be a marker of disease relapse?
Brill L; Goldberg L; Karni A; Petrou P; Abramsky O; Ovadia H; Ben-Hur T; Karussis D; Vaknin-Dembinsky A
Mult Scler; 2015 Apr; 21(5):572-9. PubMed ID: 25392324
[TBL] [Abstract][Full Text] [Related]
13. Multiple Sclerosis and Antibodies against KIR4.1.
Pröbstel AK; Kuhle J; Lecourt AC; Vock I; Sanderson NS; Kappos L; Derfuss T
N Engl J Med; 2016 Apr; 374(15):1496-8. PubMed ID: 27074084
[No Abstract] [Full Text] [Related]
14. Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients.
Marnetto F; Valentino P; Caldano M; Bertolotto A
J Immunol Methods; 2017 Jun; 445():53-58. PubMed ID: 28300540
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to potassium channels in multiple sclerosis.
Cross AH; Waubant E
N Engl J Med; 2012 Jul; 367(2):172-4. PubMed ID: 22784120
[No Abstract] [Full Text] [Related]
16. Anti-KIR4.1 Antibodies in Chinese Patients with Central Nervous System Inflammatory Demyelinating Disorders.
Zhong R; Liang J; Tao A; Wu L; Yang X; Xu H; Huang Q; Zhuang S; Long Y; Gao C
Neuroimmunomodulation; 2016; 23(5-6):295-300. PubMed ID: 28391264
[TBL] [Abstract][Full Text] [Related]
17. Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.
Navas-Madroñal M; Valero-Mut A; Martínez-Zapata MJ; Simón-Talero MJ; Figueroa S; Vidal-Fernández N; López-Góngora M; Escartín A; Querol L
PLoS One; 2017; 12(4):e0175538. PubMed ID: 28414733
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies--conflicting results?
Hemmer B
Mult Scler; 2015 Apr; 21(5):537-9. PubMed ID: 25583849
[No Abstract] [Full Text] [Related]
19. Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation.
Nicot AB; Harb J; Garcia A; Guillot F; Mai HL; Mathé CV; Morille J; Vallino A; Dugast E; Shah SP; Lefrère F; Moyon M; Wiertlewski S; Le Berre L; Renaudin K; Soulillou JP; van Pesch V; Brouard S; Berthelot L; Laplaud DA
Brain Commun; 2023; 5(2):fcad044. PubMed ID: 36910419
[TBL] [Abstract][Full Text] [Related]
20. The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via alpha-syntrophin in glia.
Connors NC; Adams ME; Froehner SC; Kofuji P
J Biol Chem; 2004 Jul; 279(27):28387-92. PubMed ID: 15102837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
